Charles Loprinzi

19PUBLICATIONS
93CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Musicology and ethnomusicologyCheminformatics and quantitative structure-activity relationshipsObstetrics and gynaecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Apr 29, 2026
Alliance A221805: Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II Study.

|Feb 13, 2026
Naloxegol, an Oral Peripherally Acting Opioid Receptor Antagonist, Administered Concurrently with First-Line Systemic Therapy for Advanced Lung Adenocarcinoma (Alliance A221504): A Feasibility and Safety Study.

Pankaj Gupta, Kalpna Gupta, Travis Dockter

|Jan 26, 2026
Alliance A222001: Oxybutynin Versus Placebo for the Treatment of Hot Flashes in Patients Receiving Androgen-Deprivation Therapy for Prostate Cancer.

Bradley J Stish, Gina L Mazza, Jones T Nauseef

|Jan 22, 2025
Musician's Experience After Breast Cancer Treatment: Defining Musical Toxicity and its Frequency.

Jessica F Burlile, Joshua D Cameron, Heather J Gunn

|Jan 08, 2025
Treatment of Established Chemotherapy-Induced Neuropathy with N-Palmitoylethanolamide: A Randomized, Double-Blind Phase II Pilot Study.

Mellar P Davis, Angela Ulrich, Rebecca Segal

|Apr 19, 2024
A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms: Results from ECOG-ACRIN E1Z11.

Vered Stearns, Opeyemi A Jegede, Victor T-S Chang

Pageof 4

Frequent Collaborators

6 joint publications

Kathryn Ruddy

3 joint publications

Maryam Lustberg

3 joint publications

Jennifer Le-Rademacher

2 joint publications

Janet E Olson